title: [Future interventional procedures for valve diseases].
abstract: BACKGROUND
  Percutaneous valve therapies represent one of the most innovative areas within interventional cardiology in the past 10 years.
  
  
  OBJECTIVE
  The aim of this work is to give an overview of current and upcoming therapeutic options.
  
  
  METHODS
  In this manuscript, the results of a retro- and prospective literature research are summarized.
  
  
  CONCLUSIONS
  With the introduction of percutaneous therapies for valvular heart disease, patients who were previously considered too ill for surgery can now be treated. The percutaneous treatment of aortic or mitral valve disease has become standard therapy. Likewise, promising results have been obtained for percutaneous treatment options for pathologies of the tricuspid valve, which are still under intense investigation.
authors.affiliation: Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland. t.thielsen@asklepios.com.
authors.forename: T
authors.initials: T
authors.lastname: Thielsen
authors.affiliation: Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland.
authors.forename: C
authors.initials: C
authors.lastname: Frerker
authors.affiliation: Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland.
authors.forename: T
authors.initials: T
authors.lastname: Schmidt
authors.affiliation: Asklepios proresearch, Hamburg, Deutschland.
authors.forename: M
authors.initials: M
authors.lastname: Schlüter
authors.affiliation: Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland.
authors.forename: F
authors.initials: F
authors.lastname: Kreidel
authors.affiliation: Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland.
authors.forename: H
authors.initials: H
authors.lastname: Alessandrini
authors.affiliation: Abteilung für Kardiologie, II. Medizinische Klinik, Asklepios Klinik St. Georg, Lohmühlenstr. 5, 20099, Hamburg, Deutschland.
authors.forename: K-H
authors.initials: KH
authors.lastname: Kuck
mesh_terms: D058385:Cardiac Valve Annuloplasty / Q000639:trends*; D019317:Evidence-Based Medicine; D005544:Forecasting; D005858:Germany; D006349:Heart Valve Diseases / Q000175:diagnosis* / Q000601:surgery*; D006350:Heart Valve Prosthesis / Q000639:trends*; D019918:Heart Valve Prosthesis Implantation / Q000639:trends*; D006801:Humans; D011300:Preoperative Care / Q000639:trends; D016896:Treatment Outcome
keywords: Catheter intervention; Mitral valve; Percutaneous treatment; Transcatheter aortic valve implantation; Tricuspid valve